Clinical Trial Update: Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of CC-90001 in subjects with pulmonary fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• CC-90001

Snippet

Sponsor: Celgene | Conditions: Pulmonary Fibrosis | Phase 1 | Status: COMPLETED